Bernard Haffey, President and CEO of NDO Surgical, Inc. will talk about the company’s first product, the Plicator®, which treats gastroesophageal reflux disease (GERD), a debilitating condition that affects 15 million Americans.
WilmerHale is a sponsor of this event, presented by the MIT Enterprise Forum of Cambridge.
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
